Angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells-Reference-Cited by-同舟云学术

Angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells

Published:2012-07 Issue:1 Volume:126 Page:124-131
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Choi Chel Hun,Park Young-Ae,Choi Jung-Joo,Song Taejong,Song Sang Yong,Lee Yoo-Young,Lee Jeong-Won,Kim Tae-Joong,Kim Byoung-Gie,Bae Duk-Soo

Funder

Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference28 articles.

1. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study;Persson;BMJ,1989

2. Hypertension and hormone-related neoplasms in women;Soler;Hypertension,1999

3. Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension;Lucenteforte;Br J Cancer,2007

4. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies;Renehan;Lancet,2008

5. Predicting the risk of endometrial cancer in postmenopausal women presenting with vaginal bleeding: the Norwich DEFAB risk assessment tool;Burbos;Br J Cancer,2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy;Journal of Nanobiotechnology;2024-07-08

2. The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer;International Journal of Molecular Sciences;2023-07-15

3. Erianin as a Promising Novel Agent in the Treatment of Neuroblastoma: The Anticancer Effects and Underlying Molecular Mechanisms;Anti-Cancer Agents in Medicinal Chemistry;2023-06

4. Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update;Non-Coding RNA;2023-04-13

5. Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment;International Journal of Molecular Sciences;2022-09-10